A clinical trial looking at the combination of a personalized mRNA cancer vaccine from Moderna and Merck’s immunotherapy drug Keytruda reportedly showed that this treatment can work to help prevent a recurrence of skin cancer.
|
|
 |
|
Skin Cancer: Vaccine May Help Prevent it From Returning |
A clinical trial looking at the combination of a personalized mRNA cancer vaccine from Moderna and Merck’s immunotherapy drug Keytruda reportedly showed that this treatment can work to help prevent a recurrence of skin cancer. |
|
|
|
|
|
|
|
|
|
|